secwatch.observer — SEC 8-K summary
======================================

Issuer:     Arch Therapeutics, Inc. (—)
CIK:        0001537561
Form:       8-K
Filed at:   2025-05-23T23:59:59+00:00
Accession:  0001641172-25-012288
Event type: other_material
Sentiment:  negative
Materiality: 1.00
Item codes: 1.03, 2.04, 3.01, 4.01, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Arch Therapeutics files Chapter 11, expects no shareholder recovery; stalking horse bid from Vivex Biologics
--------------------------------------------------------------------------------

- Filed Chapter 11 on April 18, 2025; stalking horse bid by Vivex Biologics for substantially all assets.
- Court approved bidding procedures; sale hearing set for June 20, 2025. DIP credit bid up to $900K.
- Prepetition secured parties to receive $500K carve-out; anticipated no recovery for shareholders.
- Auditor Weinberg resigned May 22, 2025; company non-compliant with SEC filings since Sep 2024 10-K.
- Securities moved to OTC Expert Market (ARTHQ); board reduced to two members, single officer.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1537561/000164117225012288/0001641172-25-012288-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1537561/000164117225012288/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-012288

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer